Human Microbiome Market is estimated to be valued at US$ 91,075.4 Mn in 2021 and is expected to exhibit a CAGR of 18.9% over the forecast period (2021-2028).

Global Human Microbiome Market, by Product Type (Foods, Diagnostic Devices/Kits, Drugs, and Others), by Application (Therapeutics and Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 46,913.4 million in 2017 and is projected to exhibit a CAGR of 17.5% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights. 

Get Sample Copy At: https://www.coherentmarketinsights.com/insight/request-sample/182

Various players in the market are adopting strategies such as collaboration with other players and research institutes, which is expected to result in expansion and development of novel medicines for various disease conditions. For instance, in 2017, AOBiome invested US$ 30 million for advancements in clinical research on systemic and topical inflammatory disorders using novel bacterial platform from iCarbonX. Efforts such as these are driving growth of the research and development of microbiome platform. In 2017, Stanford University School of Medicine and Vedanta Biosciences Inc. entered into a research collaboration to focus on food allergies in children and in patients with C. difficile infection or graft-versus-host disease. 

Browse 36 Market Data Tables and 35 Figures spread through 220 Pages and in-depth TOC on ‘Human Microbiome Market, by Product Type (Foods, Diagnostic Devices/Kits, Drugs, and Others), by Application (Therapeutics and Diagnostics), by Disease Indication (Gastrointestinal Disorders, Metabolic Disorders, Women Health, Cancer, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Forecast to 2026’ 
The rising incidence of disease conditions, where human microbiome products find applications is expected to drive growth of the market. According to data provided by the Centers for Disease Control and Prevention in October 2017, clostridium difficile infection (CDI) is among the most common healthcare-associated infections in China and Hong Kong, affecting around 36.1 cases/100,000 people in 2014, an annual increase of 26%. According to study published in Clinical Infectious Disease journal in 2015, around 25% to 33% of antibiotic-associated diarrhea and 90% of pseudomembranous enteritis are caused by CDI. 

Key Takeaways of the Human Microbiome Market:
• The global human microbiome market is expected to exhibit a CAGR of 17.5% during the forecast period. This is attributed to rising prevalence of cardiopulmonary conditions, cancer, and renal diseases.
• Among product type, foods segment held dominant position in the human microbiome market in 2017. This is due to increasing adoption of probiotics-based food and beverages, in order to maintain balance of microbiomes.
• Among disease indication, cancer segment held dominant position in the human microbiome market in 2017. In September 2018, the World Health Organization (WHO) stated that cancer is the second largest cause of deaths, globally.
• Among application, diagnostics segment accounted for major share in the human microbiome market in 2017. This is owing to emergence of diagnosis at an early stage of cancer and other diseases is proven to be beneficial in disease management.
• Major players operating in the global human microbiome market include Enterome Bioscience, Yakult Honsha Co., Ltd., DuPont, Metabiomics Corporation, ViThera Pharmaceuticals, Second Genome Inc., AOBiome LLC, Seres Therapeutics, uBiome, Inc., Rebiotix, Inc., Synthetic Biologics, Inc., MicroBiome Therapeutics LLC, Vedanta BioSciences, Osel, Inc., and Merck & Co., Inc.

To Get Instant Access, Purchase Report Here @ https://www.coherentmarketinsights.com/insight/buy-now/182

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

This release was published on openPR.